Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
Not yet recruiting · NCT07220902 · Registry updated 2025-10-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure | Female Urogenital Diseases and Pregnancy Complications, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, eclampsia, hypertension, pregnancy-induced, nervous system disorder, preeclampsia, pregnancy disorder, severe pre-eclampsia, visual epilepsy | Not yet recruiting | Phase 3 | 2025-10-24 | NCT07220902 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nebraska Methodist Health System | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Methodist Women's Hospital | Omaha | United States | 2 |